Eli Lilly and Co (LLY)
767.76
+10.22
(+1.35%)
USD |
NYSE |
Dec 20, 16:00
780.00
+12.24
(+1.59%)
After-Hours: 20:00
Eli Lilly Free Cash Flow: -2.275B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Biogen Inc | 1.768B |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Viking Therapeutics Inc | -74.25M |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.712B |
| Cash from Investing (Quarterly) | -4.005B |
| Cash from Financing (Quarterly) | 211.30M |
| Free Cash Flow Per Share (Quarterly) | -0.5071 |
| Free Cash Flow to Equity (Quarterly) | -2.687B |
| Free Cash Flow to Firm (Quarterly) | -370.39M |
| Free Cash Flow Yield | -0.33% |